Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Haemonetics Corporation (HAE : NYSE)

• Company Description    Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through proper blood management, their portfolio of products and services helps to prevent a transfusion for the patient who doesn't need one and provides the right blood product, at the right time, in the right dose to the right patient who does. Number of Employees: 2,708

• Price / Volume Information    Yesterday's Closing Price: $56.24 Daily Weekly Monthly 20 Day Moving Average: 544,722 shares Shares Outstanding: 51.11 (millions) Market Capitalization: $2,874.52 (millions) Beta: 0.44 52 Week High: $75.34 52 Week Low: $43.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.02% 8.05% 12 Week 1.30% 9.48% Year To Date 6.03% 25.59%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 125 Summer Street - Boston,MA 02110 USA ph: 781-848-7100 fax: 781-848-5106 olga.guyette@haemonetics.com http://www.haemonetics.com

• General Corporate Information    Officers Christopher A. Simon - Chief Executive Officer;President and Director William Burke - Executive Vice President; Chief Financial Officer Dan Goldstein - Vice President; Corporate Controller Robert Abernathy - Director Catherine Burzik - Director Peer Information Haemonetics Corporation (BJCT) Haemonetics Corporation (CADMQ) Haemonetics Corporation (APNO) Haemonetics Corporation (UPDC) Haemonetics Corporation (IMTIQ) Haemonetics Corporation (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 405024100 SIC: 3841 Fiscal Year Fiscal Year End: March Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/10/22 Share - Related Items Shares Outstanding: 51.11 Most Recent Split Date: 12.00 (2.00:1) Beta: 0.44 Market Capitalization: $2,874.52 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.57 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $2.72 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 10.00% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/22

• Fundamental Ratios P/E Current FY Estimate: 20.70 Trailing 12 Months: 21.71 PEG Ratio: 2.07 Price Ratios Price/Book: 3.84 Price/Cash Flow: 12.20 Price / Sales: 2.89 EPS Growth vs. Year Ago Period: 41.30% vs. Previous Quarter: -22.62% Sales Growth vs. Year Ago Period: 17.76% vs. Previous Quarter: 2.01% ROE 03/31/22 - 18.57 12/31/21 - 17.33 09/30/21 - 17.19 ROA 03/31/22 - 7.28 12/31/21 - 6.78 09/30/21 - 7.22 Current Ratio 03/31/22 - 1.71 12/31/21 - 2.05 09/30/21 - 2.42 Quick Ratio 03/31/22 - 1.05 12/31/21 - 1.19 09/30/21 - 1.31 Operating Margin 03/31/22 - 13.35 12/31/21 - 12.90 09/30/21 - 13.01 Net Margin 03/31/22 - 4.37 12/31/21 - 2.37 09/30/21 - 3.35 Pre-Tax Margin 03/31/22 - 6.41 12/31/21 - 2.19 09/30/21 - 2.88 Book Value 03/31/22 - 14.66 12/31/21 - 14.30 09/30/21 - 13.69 Inventory Turnover 03/31/22 - 1.56 12/31/21 - 1.57 09/30/21 - 1.58 Debt-to-Equity 03/31/22 - 0.75 12/31/21 - 0.87 09/30/21 - 1.00 Debt-to-Capital 03/31/22 - 42.74 12/31/21 - 46.42 09/30/21 - 49.98

Powered by Zacks Investment Research ©